Phillips, Darren C.
Jin, Sha
Gregory, Gareth P. http://orcid.org/0000-0002-4170-0682
Zhang, Qi
Xue, John
Zhao, Xiaoxian
Chen, Jun
Tong, Yunsong
Zhang, Haichao
Smith, Morey
Tahir, Stephen K.
Clark, Rick F.
Penning, Thomas D.
Devlin, Jennifer R.
Shortt, Jake
Hsi, Eric D.
Albert, Daniel H.
Konopleva, Marina
Johnstone, Ricky W.
Leverson, Joel D.
Souers, Andrew J.
Funding for this research was provided by:
The design, study conduct, and financial support for this research were provided by AbbVie Inc.
Article History
Received: 27 November 2018
Revised: 18 October 2019
Accepted: 13 November 2019
First Online: 11 December 2019
Compliance with ethical standards
:
: The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of this publication. DCP, SJ, JX, JC, YT, HZ, MS, SKT, RFC, TDP, DHA, JDL, and AJS are employees of AbbVie Inc. and are stock holders. GPG: Advisory board Takeda; speaker’s honoraria from Roche; research support from Amgen, Merck and AbbVie Inc.JS: Advisory boards, Celgene, Novartis, and BMS; speaker’s honoraria from Novartis, BMS, Roche, Amgen, and Takeda; research support from Amgen and Astex. RWJ: Research support from Abbvie Inc., Astra-Zeneca, BMS, Roche, and MecRX. MK: Advisory boards, F. Hoffman La-Roche and AbbVie; honoraria from Amgen, AbbVie, and Genentech; research funding from AbbVie, Genentech, Eli Lilly, Cellectis, Calithera, Stemline, Threshold, and Flexus; Reata Pharmaceuticals stock holder. EDH: Advisory board honoraria from Seattle Genetics and Celgene; research support from AbbVie Inc. and Eli Lilly. QZ, XZ, and JRD have nothing to disclose.